Searched over 200M research papers
2 papers analyzed
These studies suggest that Merkel cell carcinoma (MCC) is a rare and highly aggressive skin cancer, with a high rate of recurrence and mortality, emphasizing the importance of early diagnosis and treatment for better outcomes.
20 papers analyzed
Merkel cell carcinoma (MCC) is a rare and highly malignant cutaneous tumor that primarily affects the head and neck regions. It is known for its aggressive nature and high propensity for local and regional invasion, as well as a significant rate of postoperative recurrence and distant metastases, including to the thoracic, abdominal, and central nervous systems .
Conventional radiography and cross-sectional imaging are commonly used to identify lesions in MCC. These imaging techniques often reveal lesions that are similar to those seen in other small cell carcinomas, making early diagnosis challenging.
Nuclear medicine procedures, such as sentinel node scintigraphy, somatostatin receptor scintigraphy, and positron emission tomography (PET), can supplement conventional imaging. These advanced techniques add diagnostic value in staging the disease and providing therapeutic guidance.
Despite the utility of imaging, the definitive diagnosis of MCC relies on pathologic findings obtained through immunohistochemical staining and electron microscopy. These methods are crucial for accurate identification and subsequent treatment planning.
MCC is more prevalent in men, Caucasians, and the elderly. It typically appears in photo-exposed areas such as the head, trunk, and extremities. The pathogenesis of MCC is not entirely understood, but it is associated with factors such as ultraviolet radiation, immunosuppression, and polyomavirus infection.
Prompt diagnosis and treatment are essential for improving the survival rate of patients with MCC. The standard treatment involves wide-margin surgical excision of the primary tumor, followed by local and regional radiation therapy. Due to the high rate of locoregional recurrences and metastases, aggressive therapy is often required .
Merkel cell carcinoma is a rare but highly aggressive skin cancer that necessitates timely and accurate diagnosis. While imaging techniques play a crucial role in the staging and management of MCC, the definitive diagnosis relies on pathologic findings. Increased awareness and improved clinical understanding are essential for better management and treatment outcomes for this uncommon neoplasm.
Most relevant research papers on this topic